RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's ...
Late last year, the Food and Drug Administration approved the first osteoporosis treatment that stimulates bone formation, instead of slowing bone breakdown as other drugs do. Teriparatide decreased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback